Delinia
Clinical-stage biotechnology company developing selective IL-2 therapies to restore immune balance in patients with autoimmune diseases by preferentially activating regulatory T cells.
Website
https://www.delinia.com/Location
Watertown, Massachusetts, USA
Founded
2020
Investors
1
Categories
biotech, autoimmune, therapeutics, immunology, clinical-stage
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Sofinnova Partners | Paris, France | biotech-focused | seedseries-a+3 | 23 |